Eli Lilly and Company is an American pharmaceutical company headquartered in Indianapolis, Indiana, with offices in 18 countries. Its products are sold in approximately 125 countries.
| Revenue (TTM) | $79.67B |
| Gross Profit (TTM) | $66.44B |
| EBITDA | $41.71B |
| Operating Margin | 54.20% |
| Return on Equity | 102.30% |
| Return on Assets | 20.40% |
| Revenue/Share (TTM) | $89.02 |
| Book Value | $38.00 |
| Price-to-Book | 30.51 |
| Price-to-Sales (TTM) | 12.87 |
| EV/Revenue | 13.55 |
| EV/EBITDA | 25.88 |
| Quarterly Earnings Growth (YoY) | 26.20% |
| Quarterly Revenue Growth (YoY) | 47.70% |
| Shares Outstanding | $891.74M |
| Float | $888.95M |
| % Insiders | 0.16% |
| % Institutions | 85.44% |
Volatility is currently contracting
A failed cholesterol trial from Novartis (NYSE:NVS | NVS Price Prediction) is dragging the Lp(a) drug class lower and hitting Amgen (NASDAQ:AMGN) harder than any large-cap peer in Tuesday trading.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
NVO's semaglutide cuts BMI in children with obesity in phase III study, with 40.4% no longer classified as having obesity after 68 weeks.
Lilly is expanding its neuroscience pipeline through strong growth and M&A, aiming to build a new long-term driver beyond cardiometabolic therapies.
Lilly and J&J offer distinct paths for investors, with strong growth, expanding pipelines and key headwinds shaping their outlooks.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Lilly (LLY) reported earnings 30 days ago. What's next for the stock?
LLY's $2.9B Merida deal adds immunology assets and expands its pipeline beyond obesity and diabetes into new growth areas.
Employer coverage of GLP-1 drugs is collapsing heading into 2027, but the FDA just gave Eli Lilly a specific piece of ammunition that could change the conversation in payer meetings for at least one slice of that market.
INDIANAPOLIS, Sept. 1, 2026 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) will participate in the Morgan Stanley 24th Annual Global Healthcare Conference on September 14, 2026.
Tiblio connects your broker and runs your put-and-call-writing strategy for you — on LLY and any ticker you trade — then tracks every position and per-strategy win rate.
